Welcome to CDC stacks | Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years - 7468 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years
Filetype[HTML]
View this content


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Update on recommendations for use of herpes zoster vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.;
    Published:
    August 22, 2014
    Series:
    MMWR. Morbidity and mortality weekly report, Vol. 63, no. 33, p. 729-31
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    Status:
    current
    File Type:
    Filetype[PDF - 195.85 KB]
  2. Update on Recommendations for Use of Herpes Zoster Vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Published:
    Aug 22 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(33):729-731.
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    File Type:
    Filetype[PDF - 109.32 KB]
  3. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
    Personal Author:
    Dooling, Kathleen L.; Guo, Angela; Patel, Manisha; Lee, Grace M.; Moore, Kelly; Belongia, Edward A.; Harpaz, Rafael;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Jan 26 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(3):103-108.
    Description:
    On October 20, 2017, Zoster Vaccine Recombinant, Adjuvanted (Shingrix, GlaxoSmithKline, [GSK] Research Triangle Park, North Carolina), a 2-dose, subunit vaccine containing recombinant glycoprotein E in combination with a novel adjuvant (AS01|), was a...
    File Type:
    Filetype[PDF - 114.29 KB]
  4. Manual for the surveillance of vaccine-preventable diseases. Chapter 17: Varicella
    Personal Author:
    Lopez, Adriana S.; Schmid, D Scott; Bialek, Stephanie R.;
    Corporate Author:
    National Center for Immunization and Respiratory Diseases (U.S.)
    Published:
    Oct 2015
    Series:
    Manual for the surveillance of vaccine-preventable diseases ; chapter 17
    Description:
    Chapter 17 of: Manual for the surveillance of vaccine-preventable diseases. 5th edition, 2011. : Varicella (chickenpox) is a febrile rash illness resulting from primary infection with the varicella-zoster virus (VZV). Humans are the only source of in...
    File Type:
    Filetype[PDF - 392.24 KB]
  5. MMWR. Morbidity and mortality weekly report, Vol. 63, no. 33, August 22, 2014
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    August 22, 2014
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 63, no. 33
    Description:
    Vaccine-Associated Paralytic Poliomyelitis and BCG-osis in an Immigrant Child with Severe Combined Immunodeficiency Syndrome — Texas, 2013 -- Racial Disparities in Access to Maternity Care Practices That Support Breastfeeding — United States, 201...
    File Type:
    Filetype[PDF - 385.18 KB]